Access-Power & Co., Inc. (ACCR)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Access-Power & Co., Inc. (ACCR) with AI Score 61/100 (Hold). Access-Power & Co. , Inc. operates in the medical marijuana clone sector, manufacturing and distributing products under the Clones By Drones and Clones by Cars brands. Market cap: 0, Sector: Communication services.
Last analyzed: Mar 16, 2026Access-Power & Co., Inc. (ACCR) Media & Communications Profile
Access-Power & Co., Inc. focuses on manufacturing and distributing medical marijuana clones and related products. Operating under brands like Clones By Drones and Clones by Cars, the company also ventures into pet calming products. Its small size and OTC market presence differentiate it within the telecommunications services sector.
Investment Thesis
Investing in Access-Power & Co., Inc. presents a high-risk, high-reward scenario given its presence in the volatile OTC market and the evolving cannabis industry. The company's negative P/E ratio of -3.08 and a negative profit margin of -14.1% indicate financial challenges. However, a gross margin of 59.0% suggests potential profitability if operational efficiencies improve. Growth catalysts include expansion of its Clones By Drones and Clones by Cars brands and increased adoption of its pet calming products. The company's beta of 3.05 indicates high volatility, reflecting the speculative nature of the stock.
Based on FMP financials and quantitative analysis
Key Highlights
- Market capitalization of $0.00B indicates a micro-cap company with limited financial resources.
- P/E ratio of -3.08 reflects current unprofitability, requiring careful monitoring of future earnings potential.
- Gross margin of 59.0% suggests a strong potential for profitability if sales volume increases and operational costs are managed effectively.
- Beta of 3.05 indicates high volatility compared to the market, making it a higher-risk investment.
- The company operates with only 1 employee, highlighting its small scale and potential operational constraints.
Competitors & Peers
Strengths
- Niche market focus on medical marijuana clones.
- Established brand names (Clones By Drones, Clones By Cars).
- Online platform for pet calming products (mycbdpets.com).
Weaknesses
- Small scale of operations (1 employee).
- Limited financial resources (market cap of $0.00B).
- Negative profitability (negative P/E and profit margin).
Catalysts
- Ongoing: Expansion of the Clones By Drones and Clones by Cars brands through increased distribution and marketing efforts.
- Ongoing: Growing demand for calming pet products, driving increased sales through the mycbdpets.com platform.
- Upcoming: Potential regulatory changes in the cannabis industry that could create new market opportunities.
- Upcoming: Strategic partnerships with established cannabis companies to expand market reach and access new technologies.
- Ongoing: Development of new cannabis-based products to diversify the company's product line.
Risks
- Potential: Regulatory changes in the cannabis industry that could restrict or prohibit the company's operations.
- Ongoing: Intense competition from larger cannabis companies with greater financial resources.
- Potential: Fluctuations in the price of cannabis, impacting the company's profitability.
- Ongoing: Limited financial resources and small scale of operations, hindering the company's ability to compete effectively.
- Potential: Low liquidity and trading volume of the stock, making it difficult to exit positions.
Growth Opportunities
- Expansion of Clones By Drones and Clones by Cars: The company can increase its market share by expanding the distribution network for its marijuana clone products. This involves targeting new geographic markets and establishing partnerships with dispensaries and growers. The legal cannabis market is projected to reach $42.9 billion by 2027, providing a substantial growth opportunity for clone providers. Timeline: Ongoing.
- Increased Adoption of Calming Pet Products: The market for pet calming products is growing as pet owners seek natural remedies for anxiety and stress in animals. Access-Power & Co., Inc. can capitalize on this trend by expanding its mycbdpets.com platform and introducing new product offerings. The pet CBD market is expected to reach $2.5 billion by 2028. Timeline: Ongoing.
- Strategic Partnerships: Forming strategic alliances with established players in the cannabis industry can provide Access-Power & Co., Inc. with access to new markets, technologies, and resources. This includes partnerships with cultivation facilities, research institutions, and distribution networks. Timeline: 12-24 months.
- Product Diversification: Expanding the product line beyond clones and calming pet products can reduce the company's reliance on specific market segments. This includes developing new cannabis-based products, such as edibles, topicals, and concentrates. Timeline: 18-36 months.
- Online Marketing and E-commerce: Investing in online marketing and e-commerce capabilities can enhance the company's brand visibility and reach a wider customer base. This includes optimizing the mycbdpets.com platform for online sales and implementing targeted advertising campaigns. The e-commerce cannabis market is projected to grow significantly in the coming years. Timeline: Ongoing.
Opportunities
- Expansion into new geographic markets.
- Increased adoption of calming pet products.
- Strategic partnerships with established cannabis companies.
Threats
- Regulatory changes in the cannabis industry.
- Increasing competition from larger cannabis companies.
- Fluctuations in the price of cannabis.
Competitive Advantages
- Brand recognition within the niche market of marijuana clones.
- Proprietary cultivation techniques for producing high-quality clones.
- Established online platform for selling calming pet products.
About ACCR
Founded in 1996, Access-Power & Co., Inc. is a Michigan-based company specializing in the medical marijuana clone market. The company manufactures and distributes medical marijuana clones under the brand names Clones By Drones and Clones by Cars. These products are targeted towards medical marijuana growers and dispensaries. In addition to its core marijuana clone business, Access-Power & Co., Inc. also offers calming pet products through its online platform, mycbdpets.com, diversifying its product line within the broader wellness market. The company operates with a small team, reflecting its early-stage nature and focus on niche markets within the cannabis industry.
What They Do
- Manufactures medical marijuana clones.
- Distributes clones under the Clones By Drones brand.
- Distributes clones under the Clones By Cars brand.
- Offers calming pet products through mycbdpets.com.
- Operates in the cannabis industry.
- Focuses on niche markets within the cannabis sector.
Business Model
- Manufacturing and selling medical marijuana clones to growers and dispensaries.
- Selling calming pet products directly to consumers through an online platform.
- Generating revenue through product sales.
Industry Context
Access-Power & Co., Inc. operates within the evolving telecommunications services sector, specifically focusing on the niche market of medical marijuana clones and related products. The cannabis industry is characterized by rapid growth, regulatory changes, and increasing competition. While the telecommunications sector is broad, Access-Power's focus on specialized products differentiates it. The company's success depends on navigating regulatory hurdles, establishing brand recognition, and scaling operations effectively in a competitive landscape that includes both established players and emerging startups.
Key Customers
- Medical marijuana growers.
- Medical marijuana dispensaries.
- Pet owners seeking calming products.
Financials
Chart & Info
Access-Power & Co., Inc. (ACCR) stock price: Price data unavailable
Latest News
-
Stocks That Hit 52-Week Lows On Tuesday
· Mar 24, 2020
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ACCR.
Price Targets
Wall Street price target analysis for ACCR.
MoonshotScore
What does this score mean?
The MoonshotScore rates ACCR's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Patrick J. Jensen
Unknown
Patrick J. Jensen serves as the CEO of Access-Power & Co., Inc. Information regarding his detailed career history, educational background, and previous roles is not available. As the leader of a small company with only one employee, Jensen's role likely encompasses a wide range of responsibilities, from strategic planning to day-to-day operations.
Track Record: Due to limited information, it is difficult to assess Patrick J. Jensen's track record at Access-Power & Co., Inc. The company's current financial state, characterized by a negative P/E ratio and small market capitalization, suggests significant challenges. However, the gross margin of 59.0% indicates potential for improvement under his leadership.
ACCR OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Access-Power & Co., Inc. may not meet the minimum financial standards or disclosure requirements for higher tiers like OTCQB or OTCQX. Companies in this tier often have limited trading volume and may not be required to provide regular financial reports, increasing the risk for investors compared to companies listed on major exchanges like NYSE or NASDAQ.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure increases information asymmetry and makes it difficult to assess the company's true financial health.
- Low trading volume and liquidity can lead to significant price volatility and difficulty in exiting positions.
- The OTC Other tier has fewer regulatory requirements, increasing the risk of fraud or mismanagement.
- The company's small size and limited resources may hinder its ability to compete effectively in the market.
- The cannabis industry is subject to evolving regulations, which can impact the company's operations and profitability.
- Verify the company's registration and legal standing with the relevant authorities.
- Review any available financial statements and assess the company's financial health.
- Research the company's management team and their experience in the industry.
- Understand the company's business model and competitive landscape.
- Assess the liquidity and trading volume of the stock.
- Be aware of the risks associated with investing in OTC stocks.
- Consult with a financial advisor before making any investment decisions.
- The company has been in operation since 1996, suggesting some level of stability.
- The company has a registered business address in Grand Haven, Michigan.
- The company has a website (mycbdpets.com) for its pet calming products.
Access-Power & Co., Inc. Stock: Key Questions Answered
What does Access-Power & Co., Inc. do?
Access-Power & Co., Inc. operates in the cannabis industry, specializing in the production and distribution of medical marijuana clones under the brand names Clones By Drones and Clones By Cars. Additionally, the company offers calming pet products through its online platform, mycbdpets.com. The company targets medical marijuana growers, dispensaries, and pet owners, focusing on niche markets within the broader cannabis and pet wellness sectors. Its revenue is generated through product sales.
What do analysts say about ACCR stock?
There is currently no available analyst coverage for ACCR stock due to its micro-cap status and listing on the OTC Other tier. Key valuation metrics such as P/E ratio (-3.08) and profit margin (-14.1%) indicate financial challenges. Investors should focus on monitoring the company's revenue growth, gross margin (59.0%), and cash flow to assess its future potential. The high beta of 3.05 suggests significant volatility.
What are the main risks for ACCR?
The primary risks for Access-Power & Co., Inc. include regulatory uncertainties in the cannabis industry, intense competition from larger companies, and fluctuations in cannabis prices. The company's small size and limited financial resources pose operational challenges. Additionally, the stock's low liquidity and OTC Other tier listing increase investment risk due to potential price volatility and limited financial disclosure. Investors should carefully consider these factors before investing.
What are the key factors to evaluate for ACCR?
Access-Power & Co., Inc. (ACCR) currently holds an AI score of 61/100, indicating moderate score. Key strength: Niche market focus on medical marijuana clones.. Primary risk to monitor: Potential: Regulatory changes in the cannabis industry that could restrict or prohibit the company's operations.. This is not financial advice.
How frequently does ACCR data refresh on this page?
ACCR prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven ACCR's recent stock price performance?
Recent price movement in Access-Power & Co., Inc. (ACCR) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Niche market focus on medical marijuana clones.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider ACCR overvalued or undervalued right now?
Determining whether Access-Power & Co., Inc. (ACCR) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying ACCR?
Before investing in Access-Power & Co., Inc. (ACCR), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available on the company's financials and operations.
- The company's OTC listing and small market capitalization increase investment risk.
- The cannabis industry is subject to evolving regulations.